The Complete Guide to TRT Side
Effects (And How We Manage Them)

No medical treatment is without potential side effects, and testosterone replacement therapy is no exception. But here's what matters: the side effects of TRT are well-understood, predictable, and manageable with proper monitoring. The vast majority are dose-dependent — meaning they can be resolved by adjusting your protocol rather than stopping treatment entirely.

At Revive Low T Clinic, transparency about side effects is a core part of patient education. We want you to start TRT with clear eyes — knowing exactly what could happen, how likely it is, what we watch for, and what we do about it. This guide covers every significant side effect of testosterone therapy, from common to rare, with the evidence-based management strategies we use in clinical practice.

Hematocrit Elevation (Polycythemia)

What It Is

Hematocrit is the percentage of your blood volume occupied by red blood cells. Testosterone stimulates erythropoiesis — the production of red blood cells in the bone marrow. This is actually a beneficial effect at moderate levels, as it increases oxygen-carrying capacity and can improve energy and exercise performance. However, when hematocrit rises above 52 to 54 percent, blood becomes more viscous (thicker), which theoretically increases the risk of blood clots, stroke, and other thrombotic events.

How Common

Hematocrit elevation is the most common laboratory side effect of TRT. Studies report that anywhere from 5 to 20 percent of men on TRT will experience hematocrit values above 52 percent at some point during treatment. The risk is higher with injectable testosterone (which produces higher peak levels) compared to gels or patches, and higher with less frequent injections (which produce larger swings in testosterone levels).

How We Manage It

At Revive, hematocrit is monitored at every lab draw — baseline, 6 weeks, and every 3 to 6 months thereafter. Our management approach is graduated. If hematocrit rises above 50 percent, we begin watching more closely. If it approaches 52 percent, we adjust the protocol — typically by reducing the dose, increasing injection frequency (to produce more stable levels), or both. If it reaches 54 percent, we may recommend therapeutic phlebotomy (blood donation) and more significant protocol adjustments. Very rarely, if hematocrit cannot be controlled with these measures, a switch to a different testosterone delivery method (gel instead of injection) may be necessary.

Lifestyle factors that contribute to elevated hematocrit — dehydration, smoking, undiagnosed sleep apnea — are also addressed. Adequate hydration, in particular, is a simple but effective intervention that many patients overlook.

Estradiol Elevation (Aromatization)

What It Is

Testosterone is converted to estradiol (a form of estrogen) by the aromatase enzyme, which is found in adipose tissue (body fat), the liver, and other tissues. When testosterone levels increase with TRT, more substrate is available for aromatization, which can cause estradiol levels to rise above the optimal range. Elevated estradiol in men can cause water retention and bloating, mood changes (including anxiety and emotional lability), breast tissue sensitivity or growth (gynecomastia), reduced libido (paradoxically), erectile dysfunction, and increased body fat.

How Common

Clinically significant estradiol elevation occurs in approximately 10 to 20 percent of men on TRT, though mild elevation without symptoms is more common. The risk is higher in men with more body fat (because adipose tissue contains more aromatase enzyme), men on higher testosterone doses, and men with genetic variations that increase aromatase activity.

How We Manage It

Estradiol is included in our standard lab panel at every draw. When levels rise above the optimal range (typically above 40 to 50 pg/mL) and symptoms are present, we have several management options. Dose adjustment is the first line — reducing the testosterone dose or increasing injection frequency can lower peak testosterone levels and reduce aromatization. Weight loss reduces aromatase activity and is a long-term solution. If dose adjustment alone is insufficient, an aromatase inhibitor (anastrozole) may be prescribed at a low dose to control estradiol levels — this is used judiciously and monitored carefully to avoid driving estradiol too low, which carries its own risks (joint pain, bone density loss, mood changes).

Acne and Skin Changes

What It Is

Testosterone increases sebum production (the oily substance produced by sebaceous glands), which can lead to acne — particularly on the back, shoulders, and face. This is the same mechanism that causes acne during puberty, and the pattern is similar: increased oiliness, clogged pores, and inflammatory breakouts. Oily skin without actual acne breakouts is also common.

How Common

Mild to moderate acne occurs in approximately 15 to 25 percent of men starting TRT. It's more common in the first 3 to 6 months of treatment and often improves as the body adjusts. Severe acne is uncommon with physiological TRT doses. Men who had acne-prone skin in their youth are more likely to experience it on TRT.

How We Manage It

For mild acne, standard skincare measures are usually sufficient — regular cleansing with a benzoyl peroxide or salicylic acid wash, keeping the skin clean after sweating, and avoiding occlusive skincare products. For moderate acne, topical retinoids or prescription treatments may be recommended. Dose adjustment can also help — more frequent, smaller injections produce more stable hormone levels, which tends to reduce acne compared to larger, less frequent injections that produce bigger hormonal peaks.

Testicular Atrophy

What It Is

When you provide testosterone externally, your body reduces its own production through negative feedback on the HPG axis. The pituitary gland decreases LH and FSH secretion, and without these stimulating hormones, the testes reduce in size and decrease sperm production. This is a physiological response, not tissue damage — the testes aren't being harmed, they're simply reducing their workload because the body is receiving testosterone from an external source.

How Common

Some degree of testicular volume reduction occurs in the majority of men on TRT, though the degree varies. Many men don't notice any subjective change. Others report a noticeable reduction in testicular size, typically within 3 to 6 months of starting treatment.

How We Manage It

For men who are concerned about testicular atrophy or who want to preserve fertility, hCG (human chorionic gonadotropin) can be prescribed alongside TRT. hCG mimics LH and stimulates the testes to maintain their size and continue producing sperm and intratesticular testosterone. At Revive, we discuss this option with every patient during the initial consultation — particularly men who may want to have children in the future.

Fertility Suppression

What It Is

As described above, TRT suppresses the HPG axis, which significantly reduces or eliminates sperm production in most men. This is not permanent in most cases — sperm production typically recovers after TRT is discontinued, though recovery can take 3 to 12 months or longer in some cases. However, TRT should never be used as a reliable contraceptive method, as some men maintain residual sperm production.

How We Manage It

Fertility planning is part of every initial consultation at Revive. For men who may want children, we offer several approaches: hCG alongside TRT to maintain spermatogenesis, clomiphene citrate as an alternative to exogenous testosterone (it stimulates the body's own production while preserving fertility), or semen cryopreservation (sperm banking) before starting TRT. The key is addressing this before treatment starts — not after months of suppression. For more on this topic, see our article on TRT myths debunked, which covers the infertility myth in detail.

Hair Changes

What It Is

Testosterone is converted to dihydrotestosterone (DHT) by the 5-alpha-reductase enzyme. DHT is the androgen primarily responsible for male pattern hair loss — it miniaturizes hair follicles in genetically susceptible areas of the scalp (temples, crown). When testosterone levels increase with TRT, DHT levels typically increase proportionally, which can accelerate hair thinning in men who are genetically predisposed to male pattern baldness. Conversely, TRT can increase body and facial hair growth.

How Common

Noticeable acceleration of scalp hair thinning is reported by approximately 5 to 10 percent of men on TRT. This primarily affects men who already have some degree of male pattern baldness or a strong family history of it. Men without the genetic predisposition are unlikely to experience significant hair changes.

How We Manage It

For men concerned about hair loss, we discuss this risk before starting TRT. Management options include finasteride or dutasteride (5-alpha-reductase inhibitors that block the conversion of testosterone to DHT), topical minoxidil, or simply monitoring without intervention if the rate of hair thinning is acceptable to the patient. The decision is always a personal one — some men prioritize hair preservation, while others consider the benefits of TRT more important than potential hair thinning.

Sleep Apnea

What It Is

There has been historical concern that testosterone therapy may worsen obstructive sleep apnea (OSA) by affecting upper airway muscle tone and fat distribution in the neck area. The evidence on this is mixed — some studies suggest a modest worsening in untreated OSA patients, while others show no significant effect. The relationship is further complicated by the fact that obesity (which worsens sleep apnea) and low testosterone frequently coexist.

How We Manage It

At Revive, we screen every patient for sleep apnea risk factors during the initial evaluation. If OSA is suspected, we refer for a sleep study before or early in TRT treatment. If OSA is diagnosed, it should be treated with CPAP or another appropriate therapy alongside TRT — not instead of it. We also monitor for new or worsening sleep symptoms during follow-up visits. For men already on CPAP, TRT is generally safe and the combination can improve both conditions simultaneously. Read more in our article on testosterone and sleep.

Mood Changes

What It Is

While TRT generally improves mood in men with low testosterone, some men experience mood changes during the adjustment period — particularly if dosing isn't optimized. Irritability can occur when testosterone levels are too high, or when estradiol levels rise above optimal range. Some men experience emotional volatility during the first few weeks as their hormonal system adjusts. These effects are almost always dose-dependent and temporary.

How We Manage It

Mood assessment is part of every follow-up visit. If mood changes occur, we first check lab values — elevated testosterone or estradiol are the most common culprits. Dose adjustment typically resolves the issue. If mood changes persist despite optimized lab values, we explore other potential causes and may recommend consultation with a mental health professional. For more on the relationship between hormones and mood, read our article on low testosterone and depression.

Injection Site Reactions

For men on injectable testosterone (the most common form), injection site reactions are the most frequently reported side effect — and the most benign. These can include mild pain or soreness at the injection site (lasting 1 to 3 days), small bruises, or occasionally a hard lump under the skin. These are normal consequences of intramuscular or subcutaneous injection and improve with technique refinement.

At Revive, we provide hands-on injection training during your first visit — a nurse or physician walks you through the proper technique, watches you perform it, and ensures you're comfortable. Proper technique, site rotation, and appropriate needle gauge reduce injection site reactions significantly. Many patients report that injections become completely painless within a few weeks as they refine their technique.

Rare but Serious Side Effects

For completeness, these are side effects that are rare at physiological TRT doses but deserve mention:

• Venous thromboembolism (blood clots) — The TRAVERSE trial showed a slightly higher rate of pulmonary embolism in the testosterone group (0.9% vs. 0.5%), though overall venous thromboembolism rates were not statistically different. Hematocrit monitoring is the primary safeguard.
• Liver toxicity — Primarily associated with oral methyltestosterone (rarely used today) rather than injectable testosterone cypionate. Liver function is monitored as part of our standard panel.
• Allergic reactions — Rare, but can occur in response to the carrier oil (cottonseed or sesame oil) or preservatives. If an allergy is identified, compounded testosterone in an alternative carrier oil is prescribed.

Why In-Person Monitoring Matters

Every side effect listed in this article is manageable — but only if it's detected. This is the core argument for comprehensive, in-person TRT care rather than telehealth models with basic lab work and infrequent follow-up. A hematocrit trending upward is only caught if you're testing for it. Estradiol elevation is only identified if it's included in your panel. Sleep apnea is only screened for if your physician sees you in person and asks the right questions.

At Revive, our monitoring protocol is designed to catch every potential side effect early — before it becomes a problem. Your initial 51-analyte panel establishes baselines. Your 6-week follow-up catches early changes. Ongoing monitoring every 3 to 6 months tracks trends over time. And seeing the same physician at every visit means your provider knows your history, your response patterns, and your individual risk profile.